Finance

Beta
Lists
SNTI:NASDAQ
Senti Biosciences Holdings Inc
$0.97
-3.46%
(-0.035) 1D
$0.95
-2.00% (-0.019)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNTI...
Open
$0.97
High
$1.00
Low
$0.94
Mkt. cap
30.07M
Avg. vol.
209.93K
Volume
225.64K
52-wk high
$3.88
52-wk low
$0.77
EPS
-$1.92
Beta
2.08
Shares outstanding
31.14M
No. of employees
39
Open
$0.97
High
$1.00
Low
$0.94
Mkt. cap
30.07M
Avg. vol.
209.93K
Volume
225.64K
52-wk high
$3.88
52-wk low
$0.77
EPS
-$1.92
Beta
2.08
Shares outstanding
31.14M
No. of employees
39
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to SNTI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SNTI in the last 3 months.
Highest
Current $0.97
$12.00 (+1,143.01%)
Average
$12.00 (+1,143.01%)
Lowest
$12.00 (+1,143.01%)
News stories
From sources across the web
About Senti Biosciences Holdings Inc
CEO-
Employees39
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
22.00K
16.00K
Cost of goods sold
10.03M
10.52M
7.76M
-
Cost of revenue
10.03M
10.52M
7.76M
-
Research and development expenses
-
-
-
5.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.18M
8.00M
423.00K
6.15M
Operating expense
5.18M
8.00M
423.00K
11.43M
Total operating expenses
15.21M
18.52M
8.18M
11.43M
Operating income
-15.21M
-18.52M
-8.16M
-11.42M
Other non operating income
209.00K
223.00K
-1.35M
214.00K
EBT including unusual items
-14.73M
-18.13M
-14.47M
-4.22M
EBT excluding unusual items
-14.73M
-18.13M
-9.42M
-11.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.73M
-18.13M
-14.47M
-4.22M
Net profit margin
-
-
-65,759.09%
-26,381.25%
Earnings per share
-0.56
-0.69
-0.53
-0.14
Interest and investment income
270.00K
166.00K
97.00K
101.00K
Interest expense
-
-
-
-
Net interest expenses
270.00K
166.00K
97.00K
101.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.30M
-17.61M
-7.27M
-10.51M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more